The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Mullan, RH, Lobanok, T, Walsh, C, King, L, FitzGerald, O, Bresnihan, B, Fearon, U, Poole, R, Veale, DJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834059/
http://dx.doi.org/10.1186/ar1581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834059/
http://dx.doi.org/10.1186/ar1581

Ejemplares similares